Eli Lilly Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill could be approved in early 2026. He speaks to Bloomberg's Katie Greifeld from the JPMorgan Healthcare Conference in San Francisco.

Eli Lilly Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill could be approved in early 2026. He speaks to Bloomberg's Katie Greifeld from the JPMorgan Healthcare Conference in San Francisco.

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4533335d-1e9a-4d60-ab8b-b2640108d199/transcript

The U.S. crypto industry faces a legislative test on Sept. 15, when the Senate is scheduled to hold a procedural vote on the CLARITY Act. For more, Tim Stenovec and Scarlet Fu speak with Coinbase Vice Chair Ryan Vangrack 

The U.S. crypto industry faces a legislative test on Sept. 15, when the Senate is scheduled to hold a procedural vote on the CLARITY Act. For more, Tim Stenovec and Scarlet Fu speak with&nbsp;Coinbase Vice Chair Ryan Vangrack&nbsp;

Coinbase Vice Chair Ryan Vangrack Talks CLARITY Act

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/660dc854-544c-4d3e-90f9-b4bf012fc56e/transcript

Michigan Democratic US Senate candidate Abdul El-Sayed countered Republican criticism that his progressive-leaning platform is out of step with mainstream Americans by lambasting President Donald Trump’s tariffs on US trading partners, the unpopular war in Iran and the high cost of living Americans confront. He speaks with Bloomberg's Kailey Leinz. 

Michigan Democratic US Senate candidate Abdul El-Sayed countered Republican criticism that his progressive-leaning platform is out of step with mainstream Americans by lambasting President Donald Trump&rsquo;s tariffs on US trading partners, the unpopular war in Iran and the high cost of living Americans confront. He speaks with Bloomberg's Kailey Leinz.&nbsp;

US Senate Candidate Abdul El-Sayed Talks Midterm Election

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/8a4911c8-4b02-46de-86cd-b4bf012dee2b/transcript

Steve O'Donnell, NASCAR CEO, says the business has good momentum but he's still focused on attracting younger viewers and getting new fans to the track. He also talks about competition among the drivers and how that helps the sport. He speaks with Bloomberg's Bailey Lipshultz and Randall Williams. 

Steve O'Donnell, NASCAR CEO, says the business has good momentum but he's still focused on attracting younger viewers and getting new fans to the track. He also talks about competition among the drivers and how that helps the sport. He speaks with Bloomberg's Bailey Lipshultz and Randall Williams.&nbsp;

Nascar CEO Steve O'Donnell Talks Reshaping Business

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/eb39aca5-4380-4c67-82c1-b4bf01052fe6/transcript

Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips